Securities ▲▼ | Shares | Value | |||||
|---|---|---|---|---|---|---|---|
Q4 2025 ▲▼ | Q1 2026 ▲▼ | Change ▲▼ | Q4 2025 ▲▼ | Q1 2026 ▲▼ | Weight (%) ▲▼ | Change ▲▼ | |
| Dianthus Therapeutics, Inc.(DNTH) | 2,416,667 | 1,946,667 | -470,000 | $99.59M | $163.36M | 18.08% | +$63.77M |
| Cogent Biosciences, Inc.(COGT) | 2,350,000 | 2,350,000 | 0 | $83.47M | $90.45M | 10.01% | +$6.98M |
| ABIVAX Société AnonymeADS(ABVX) | 756,000 | 677,000 | -79,000 | $101.95M | $75.38M | 8.34% | -$26.57M |
| Alumis Inc | 2,530,700 | 2,830,700 | +300,000 | $24.70M | $62.36M | 6.90% | +$37.66M |
| Definium Therapeutics, Inc.(DFTX) | 0 | 2,440,000 | +2,440,000 | $0 | $46.12M | 5.10% | +$46.12M |
| ArriVent BioPharma, Inc.(AVBP) | 1,971,054 | 1,971,054 | 0 | $39.66M | $45.47M | 5.03% | +$5.81M |
| Taysha Gene Therapies, Inc.(TSHA) | 8,859,911 | 8,859,911 | 0 | $48.73M | $39.60M | 4.38% | -$9.13M |
| Kymera Therapeutics, Inc.(KYMR) | 535,000 | 425,000 | -110,000 | $41.63M | $35.40M | 3.92% | -$6.23M |
| Mirum Pharmaceuticals, Inc.(MIRM) | 0 | 338,900 | +338,900 | $0 | $31.31M | 3.46% | +$31.31M |
| BioAge Labs, Inc.(BIOA) | 1,598,000 | 1,748,000 | +150,000 | $21.14M | $30.57M | 3.38% | +$9.43M |
| Centessa Pharmaceuticals PlcADS | 750,000 | 750,000 | 0 | $18.76M | $29.79M | 3.30% | +$11.03M |
| Kalvista Pharmaceuticals Inc | 1,273,333 | 1,450,000 | +176,667 | $20.56M | $29.19M | 3.23% | +$8.62M |
| Xenon Pharmaceuticals Inc.(XENE) | 0 | 490,000 | +490,000 | $0 | $28.49M | 3.15% | +$28.49M |
| Terns Pharmaceuticals Inc | 0 | 530,000 | +530,000 | $0 | $27.94M | 3.09% | +$27.94M |
| Ocular Therapeutix, Inc.(OCUL) | 2,623,600 | 3,166,600 | +543,000 | $31.85M | $26.82M | 2.97% | -$5.03M |
| Palisade Bio, Inc.(PALI) | 9,567,898 | 10,276,317 | +708,419 | $22.48M | $17.98M | 1.99% | -$4.50M |
| Trevi Therapeutics, Inc.(TRVI) | 2,815,000 | 1,485,000 | -1,330,000 | $35.24M | $17.72M | 1.96% | -$17.53M |
| Disc Medicine, Inc.(IRON) | 0 | 270,000 | +270,000 | $0 | $17.26M | 1.91% | +$17.26M |
| Aktis Oncology, Inc.(AKTS) | 0 | 960,847 | +960,847 | $0 | $17.19M | 1.90% | +$17.19M |
| Context Therapeutics Inc.(CNTX) | 0 | 5,250,000 | +5,250,000 | $0 | $13.76M | 1.52% | +$13.76M |
| Precision BioSciences, Inc.(DTIL) | 1,917,995 | 2,236,732 | +318,737 | $7.98M | $12.30M | 1.36% | +$4.32M |
| DBV Technologies S.A.ADS(DBVT) | 574,200 | 574,200 | 0 | $11.01M | $12.00M | 1.33% | +$987.6K |
| Unicycive Therapeutics, Inc.(UNCY) | 1,000,000 | 1,000,000 | 0 | $5.77M | $6.58M | 0.73% | +$810.0K |
| BridgeBio Oncology Therapeutics, Inc.(BBOT) | 1,043,110 | 719,000 | -324,110 | $13.06M | $6.44M | 0.71% | -$6.62M |
| Lexeo Therapeutics, Inc.(LXEO) | 1,725,000 | 1,100,000 | -625,000 | $17.13M | $6.31M | 0.70% | -$10.82M |
| Pharvaris N V COM | 671,465 | 165,000 | -506,465 | $18.63M | $4.66M | 0.52% | -$13.97M |
| Perspective Therapeutics, Inc.(CATX) | 0 | 791,555 | +791,555 | $0 | $3.30M | 0.37% | +$3.30M |
| Evommune, Inc.(EVMN) | 500,000 | 143,472 | -356,528 | $8.56M | $3.30M | 0.37% | -$5.26M |
| Gossamer Bio, Inc.(GOSS) | 13,915,371 | 7,750,000 | -6,165,371 | $43.14M | $2.55M | 0.28% | -$40.59M |
| Cidara Therapeutics Inc | 100,000 | 0 | -100,000 | $22.09M | $0 | — | -$22.09M |
| Corbus Pharmaceuticals Holdings, Inc.(CRBP) | 955,000 | 0 | -955,000 | $7.77M | $0 | — | -$7.77M |
| Mind Medicine Mindmed Inc | 2,230,000 | 0 | -2,230,000 | $29.86M | $0 | — | -$29.86M |
| PepGen Inc.(PEPG) | 700,000 | 0 | -700,000 | $4.56M | $0 | — | -$4.56M |
| Rapt Therapeutics Inc | 574,000 | 0 | -574,000 | $19.44M | $0 | — | -$19.44M |